PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 8, 2026Current Opinion in Oncology2 citations

Tumor microenvironment-driven immune evasion and therapeutic strategies in head and neck squamous cell carcinoma

View Full Paper
ITIngeborg TinhoferAFAnne-Sophie Fisch

Key Points

  • This research aims to explore the role of the tumor microenvironment in immune evasion and therapeutic strategies for HNSCC.
  • Discussion of the tumor microenvironment (TME) in head and neck squamous cell carcinoma (HNSCC)
  • Analysis of therapeutic strategies targeting TME-driven immune evasion
  • Evaluation of clinical trials embedding high-resolution TME profiling
  • Identified the tumor microenvironment as a barrier to effective therapy in HNSCC
  • Proposed TME profiling to optimize patient selection for immunotherapy
  • Emphasized the importance of TME-matched combinations for durable patient benefit

Abstract

The HNSCC TME is both a central barrier and an attractive therapeutic target. Embedding high-resolution TME profiling into clinical trials will be crucial to select TME-matched combinations and identify patient subsets most likely to derive durable benefit from immunotherapy.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Tinhofer et al. (2026) studied this question.

synapsesocial.com/papers/69acc57d32b0ef16a404fb2ehttps://doi.org/10.1097/cco.0000000000001212
Ask AI
Helpful
Bookmark
Share
View Full Paper